Global TB Vaccines Market Insights, Forecast to 2025

Publisher Name :
Date: 06-Jun-2019
No. of pages: 112
Inquire Before Buying

Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-Guérin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defence against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%.Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.

The global TB Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the TB Vaccines market based on company, product type, end user and key regions.

This report studies the global market size of TB Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of TB Vaccines in these regions.

This research report categorizes the global TB Vaccines market by top players/brands, region, type and end user. This report also studies the global TB Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Merck & Co.,Inc

- Sanofi Pasteur

- Japan BCG Laboratory

- China National Biotec Group

- Serum Institute

- India Pvt. Ltd

- InterVax Ltd

- GreenSignal

- Bio Pharma Limited

- Statens Serum Institut

Market size by Product

- Mobile

- Benchtop

Market size by End User

- For Water Analysis

- Measuring

- Laboratory

- Others

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global TB Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of TB Vaccines market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global TB Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of TB Vaccines submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of TB Vaccines are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of TB Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global TB Vaccines Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 TB Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global TB Vaccines Market Size Growth Rate by Product
1.4.2 Mobile
1.4.3 Benchtop
1.5 Market by End User
1.5.1 Global TB Vaccines Market Size Growth Rate by End User
1.5.2 For Water Analysis
1.5.3 Measuring
1.5.4 Laboratory
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global TB Vaccines Market Size
2.1.1 Global TB Vaccines Revenue 2014-2025
2.1.2 Global TB Vaccines Sales 2014-2025
2.2 TB Vaccines Growth Rate by Regions
2.2.1 Global TB Vaccines Sales by Regions
2.2.2 Global TB Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 TB Vaccines Sales by Manufacturers
3.1.1 TB Vaccines Sales by Manufacturers
3.1.2 TB Vaccines Sales Market Share by Manufacturers
3.1.3 Global TB Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 TB Vaccines Revenue by Manufacturers
3.2.1 TB Vaccines Revenue by Manufacturers (2014-2019)
3.2.2 TB Vaccines Revenue Share by Manufacturers (2014-2019)
3.3 TB Vaccines Price by Manufacturers
3.4 TB Vaccines Manufacturing Base Distribution, Product Types
3.4.1 TB Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers TB Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into TB Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global TB Vaccines Sales by Product
4.2 Global TB Vaccines Revenue by Product
4.3 TB Vaccines Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global TB Vaccines Breakdown Data by End User
6 North America
6.1 North America TB Vaccines by Countries
6.1.1 North America TB Vaccines Sales by Countries
6.1.2 North America TB Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America TB Vaccines by Product
6.3 North America TB Vaccines by End User
7 Europe
7.1 Europe TB Vaccines by Countries
7.1.1 Europe TB Vaccines Sales by Countries
7.1.2 Europe TB Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe TB Vaccines by Product
7.3 Europe TB Vaccines by End User
8 Asia Pacific
8.1 Asia Pacific TB Vaccines by Countries
8.1.1 Asia Pacific TB Vaccines Sales by Countries
8.1.2 Asia Pacific TB Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific TB Vaccines by Product
8.3 Asia Pacific TB Vaccines by End User
9 Central & South America
9.1 Central & South America TB Vaccines by Countries
9.1.1 Central & South America TB Vaccines Sales by Countries
9.1.2 Central & South America TB Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America TB Vaccines by Product
9.3 Central & South America TB Vaccines by End User
10 Middle East and Africa
10.1 Middle East and Africa TB Vaccines by Countries
10.1.1 Middle East and Africa TB Vaccines Sales by Countries
10.1.2 Middle East and Africa TB Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa TB Vaccines by Product
10.3 Middle East and Africa TB Vaccines by End User
11 Company Profiles
11.1 Merck & Co.,Inc
11.1.1 Merck & Co.,Inc Company Details
11.1.2 Company Business Overview
11.1.3 Merck & Co.,Inc TB Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Merck & Co.,Inc TB Vaccines Products Offered
11.1.5 Merck & Co.,Inc Recent Development
11.2 Sanofi Pasteur
11.2.1 Sanofi Pasteur Company Details
11.2.2 Company Business Overview
11.2.3 Sanofi Pasteur TB Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Sanofi Pasteur TB Vaccines Products Offered
11.2.5 Sanofi Pasteur Recent Development
11.3 Japan BCG Laboratory
11.3.1 Japan BCG Laboratory Company Details
11.3.2 Company Business Overview
11.3.3 Japan BCG Laboratory TB Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Japan BCG Laboratory TB Vaccines Products Offered
11.3.5 Japan BCG Laboratory Recent Development
11.4 China National Biotec Group
11.4.1 China National Biotec Group Company Details
11.4.2 Company Business Overview
11.4.3 China National Biotec Group TB Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.4.4 China National Biotec Group TB Vaccines Products Offered
11.4.5 China National Biotec Group Recent Development
11.5 Serum Institute
11.5.1 Serum Institute Company Details
11.5.2 Company Business Overview
11.5.3 Serum Institute TB Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Serum Institute TB Vaccines Products Offered
11.5.5 Serum Institute Recent Development
11.6 India Pvt. Ltd
11.6.1 India Pvt. Ltd Company Details
11.6.2 Company Business Overview
11.6.3 India Pvt. Ltd TB Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.6.4 India Pvt. Ltd TB Vaccines Products Offered
11.6.5 India Pvt. Ltd Recent Development
11.7 InterVax Ltd
11.7.1 InterVax Ltd Company Details
11.7.2 Company Business Overview
11.7.3 InterVax Ltd TB Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.7.4 InterVax Ltd TB Vaccines Products Offered
11.7.5 InterVax Ltd Recent Development
11.8 GreenSignal
11.8.1 GreenSignal Company Details
11.8.2 Company Business Overview
11.8.3 GreenSignal TB Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.8.4 GreenSignal TB Vaccines Products Offered
11.8.5 GreenSignal Recent Development
11.9 Bio Pharma Limited
11.9.1 Bio Pharma Limited Company Details
11.9.2 Company Business Overview
11.9.3 Bio Pharma Limited TB Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Bio Pharma Limited TB Vaccines Products Offered
11.9.5 Bio Pharma Limited Recent Development
11.10 Statens Serum Institut
11.10.1 Statens Serum Institut Company Details
11.10.2 Company Business Overview
11.10.3 Statens Serum Institut TB Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Statens Serum Institut TB Vaccines Products Offered
11.10.5 Statens Serum Institut Recent Development
12 Future Forecast
12.1 TB Vaccines Market Forecast by Regions
12.1.1 Global TB Vaccines Sales Forecast by Regions 2019-2025
12.1.2 Global TB Vaccines Revenue Forecast by Regions 2019-2025
12.2 TB Vaccines Market Forecast by Product
12.2.1 Global TB Vaccines Sales Forecast by Product 2019-2025
12.2.2 Global TB Vaccines Revenue Forecast by Product 2019-2025
12.3 TB Vaccines Market Forecast by End User
12.4 North America TB Vaccines Forecast
12.5 Europe TB Vaccines Forecast
12.6 Asia Pacific TB Vaccines Forecast
12.7 Central & South America TB Vaccines Forecast
12.8 Middle East and Africa TB Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 TB Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure TB Vaccines Product Picture
Table TB Vaccines Market Segments
Table Key Manufacturers TB Vaccines Covered
Table Global TB Vaccines Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global TB Vaccines Sales Market Share by Product 2014-2025
Figure Mobile Product Picture
Table Major Manufacturers of Mobile
Figure Benchtop Product Picture
Table Major Manufacturers of Benchtop
Table Global TB Vaccines Market Size Growth Rate by End User 2019-2025 (K Units)
Figure For Water Analysis
Figure Measuring
Figure Laboratory
Figure Others
Figure TB Vaccines Report Years Considered
Figure Global TB Vaccines Market Size 2014-2025 (Million US$)
Figure Global TB Vaccines Sales 2014-2025 (K Units)
Table Global TB Vaccines Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global TB Vaccines Sales by Regions 2014-2019 (K Units)
Table Global TB Vaccines Sales Market Share by Regions 2014-2019
Figure Global TB Vaccines Sales Market Share by Regions 2014-2019
Figure 2018 Global TB Vaccines Sales Market Share by Regions
Table Global TB Vaccines Revenue by Regions 2014-2019 (Million US$)
Table Global TB Vaccines Revenue Market Share by Regions 2014-2019
Figure Global TB Vaccines Revenue Market Share by Regions 2014-2019
Figure 2018 Global TB Vaccines Revenue Market Share by Regions
Table Global TB Vaccines Sales by Manufacturers (2014-2019) (K Units)
Table Global TB Vaccines Sales Share by Manufacturers (2014-2019)
Figure Global TB Vaccines Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table TB Vaccines Revenue by Manufacturers (2014-2019) (Million USD)
Table TB Vaccines Revenue Share by Manufacturers (2014-2019)
Figure TB Vaccines Value Share by Manufacturers in 2018
Table Key Manufacturers TB Vaccines Price (2014-2019) (USD/Unit)
Table TB Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers TB Vaccines Product Type
Table Date of International Manufacturers Enter into TB Vaccines Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global TB Vaccines Sales by Product (2014-2019) (K Units)
Table Global TB Vaccines Sales Share by Product (2014-2019)
Figure Global TB Vaccines Sales Market Share by Product (2014-2019)
Figure Global TB Vaccines Sales Market Share by Product in 2018
Table Global TB Vaccines Revenue by Product (2014-2019) (Million US$)
Table Global TB Vaccines Revenue Share by Product (2014-2019)
Figure Global TB Vaccines Revenue Market Share by Product (2014-2019)
Figure Global TB Vaccines Revenue Market Share by Product in 2018
Table TB Vaccines Price by Product 2014-2019 (USD/Unit)
Table Global TB Vaccines Sales by End User (2014-2019) (K Units)
Table Global TB Vaccines Sales Share by End User (2014-2019)
Figure Global Sales TB Vaccines Market Share by End User (2014-2019)
Figure Global Sales TB Vaccines Market Share by End User in 2018
Figure North America TB Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure North America TB Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table North America TB Vaccines Sales by Countries (2014-2019) (K Units)
Table North America TB Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 North America TB Vaccines Sales Market Share by Countries
Table North America TB Vaccines Revenue by Countries (2014-2019) (Million US$)
Table North America TB Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 North America TB Vaccines Revenue Market Share by Countries
Figure United States TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure United States TB Vaccines Revenue Growth Rate (2014-2019) (K Units)
Figure Canada TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Canada TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Mexico TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table North America TB Vaccines Sales by Product (2014-2019) (K Units)
Table North America TB Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 North America TB Vaccines Market Share by Product
Table North America TB Vaccines Sales by End User (2014-2019) (K Units)
Table North America TB Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 North America TB Vaccines Market Share by End User
Figure Europe TB Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Europe TB Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Europe TB Vaccines Sales by Countries (2014-2019) (K Units)
Table Europe TB Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Europe TB Vaccines Sales Market Share by Countries
Table Europe TB Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Europe TB Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe TB Vaccines Revenue Market Share by Countries
Figure Germany TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Germany TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure France TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure France TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure UK TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure UK TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Italy TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Russia TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Europe TB Vaccines Sales by Product (2014-2019) (K Units)
Table Europe TB Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Europe TB Vaccines Market Share by Product
Table Europe TB Vaccines Sales by End User (2014-2019) (K Units)
Table Europe TB Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Europe TB Vaccines Market Share by End User
Figure Asia Pacific TB Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific TB Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific TB Vaccines Sales by Countries (2014-2019) (K Units)
Table Asia Pacific TB Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific TB Vaccines Sales Market Share by Countries
Table Asia Pacific TB Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific TB Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific TB Vaccines Revenue Market Share by Countries
Figure China TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure China TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Japan TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Korea TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure India TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure India TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Australia TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Philippines TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Thailand TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Singapore TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific TB Vaccines Sales by Product (2014-2019) (K Units)
Table Asia Pacific TB Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific TB Vaccines Market Share by Product
Table Asia Pacific TB Vaccines Sales by End User (2014-2019) (K Units)
Table Asia Pacific TB Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific TB Vaccines Market Share by End User
Figure Central & South America TB Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America TB Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America TB Vaccines Sales by Countries (2014-2019) (K Units)
Table Central & South America TB Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America TB Vaccines Sales Market Share by Countries
Table Central & South America TB Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Central & South America TB Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America TB Vaccines Revenue Market Share by Countries
Figure Brazil TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Brazil TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Argentina TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America TB Vaccines Sales by Product (2014-2019) (K Units)
Table Central & South America TB Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America TB Vaccines Market Share by Product
Table Central & South America TB Vaccines Sales by End User (2014-2019) (K Units)
Table Central & South America TB Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America TB Vaccines Market Share by End User
Figure Middle East and Africa TB Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa TB Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa TB Vaccines Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa TB Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa TB Vaccines Sales Market Share by Countries
Table Middle East and Africa TB Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa TB Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa TB Vaccines Revenue Market Share by Countries
Figure GCC Countries TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Turkey TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Egypt TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa TB Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure South Africa TB Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa TB Vaccines Sales by Product (2014-2019) (K Units)
Table Middle East and Africa TB Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa TB Vaccines Market Share by Product
Table Middle East and Africa TB Vaccines Sales by End User (2014-2019) (K Units)
Table Middle East and Africa TB Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa TB Vaccines Market Share by End User
Table Merck & Co.,Inc Company Details
Table Merck & Co.,Inc TB Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck & Co.,Inc Recent Development
Table Sanofi Pasteur Company Details
Table Sanofi Pasteur TB Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Pasteur Recent Development
Table Japan BCG Laboratory Company Details
Table Japan BCG Laboratory TB Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Japan BCG Laboratory Recent Development
Table China National Biotec Group Company Details
Table China National Biotec Group TB Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table China National Biotec Group Recent Development
Table Serum Institute Company Details
Table Serum Institute TB Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Serum Institute Recent Development
Table India Pvt. Ltd Company Details
Table India Pvt. Ltd TB Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table India Pvt. Ltd Recent Development
Table InterVax Ltd Company Details
Table InterVax Ltd TB Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table InterVax Ltd Recent Development
Table GreenSignal Company Details
Table GreenSignal TB Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GreenSignal Recent Development
Table Bio Pharma Limited Company Details
Table Bio Pharma Limited TB Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bio Pharma Limited Recent Development
Table Statens Serum Institut Company Details
Table Statens Serum Institut TB Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Statens Serum Institut Recent Development
Table Global TB Vaccines Sales Forecast by Regions 2019-2025 (K Units)
Table Global TB Vaccines Sales Market Share Forecast by Regions 2019-2025
Table Global TB Vaccines Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global TB Vaccines Revenue Market Share Forecast by Regions 2019-2025
Table Global TB Vaccines Sales Forecast by Product 2019-2025 (K Units)
Table Global TB Vaccines Sales Market Share Forecast by Product 2019-2025
Table Global TB Vaccines Revenue Forecast by Product 2019-2025 (Million US$)
Table Global TB Vaccines Revenue Market Share Forecast by Product 2019-2025
Table Global TB Vaccines Sales Forecast by End User 2019-2025 (K Units)
Table Global TB Vaccines Sales Market Share Forecast by End User 2019-2025
Figure North America TB Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America TB Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe TB Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe TB Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific TB Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific TB Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America TB Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America TB Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa TB Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa TB Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table TB Vaccines Value Chain
Table TB Vaccines Customers List
Table TB Vaccines Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs